US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients (March 5)
Shares of the company were up 5.2% in extended trading. The spray, sold under the brand name neffy, will be dosed at 1 milligram (mg) for the new patient population, compared to the previously ...
Spring allergy season is around the corner. Here's what you can do to deal with congestion.
The start of spring kicks off a nasal nuisance for many people, but one drug meant to clear congestion has struggled to do ...
Newsweek on MSN27d
Nationwide Chocolate Cone Recall Over 'Serious' Allergic Reaction Warning
Kayco's Glicks Dark Chocolate Conettos may contain undeclared milk, which can cause a serious reaction in people with an allergy or severe sensitivity to it.
Healthline8d
7 Food Allergy Mistakes It’s Easy to Make
Food allergies occur when your body reacts to a food particle as if it were harmful. Even when you’re aware of a food allergy ...
WebMD15d
FDA OKs Nasal Spray for Severe Allergic Reactions in Kids
The FDA has approved Neffy, a needle-free nasal spray, for children aged 4 and up, providing fast and effective treatment for ...
Medical Xpress16d
FDA expands indication of dust mite allergy drug to include young children
The U.S. Food and Drug Administration has expanded its indication of ... to include children ages 5 through 11 years. Odactra is an allergy immunotherapy and is administered sublingually as a small ...
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Cash Position & Operating Runway : As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments of $314.0 million, with 97,954,172 shares of common stock outstanding. The ...
US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients
The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...